{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:19:07Z","timestamp":1788221947065,"version":"build-2803163510"},"reference-count":210,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T00:00:00Z","timestamp":1772755200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Blood Reviews"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.blre.2026.101365","type":"journal-article","created":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T16:50:35Z","timestamp":1772038235000},"page":"101365","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Reinventing the wheel in ischemic stroke: Novel aspects in ADAMTS13 and von Willebrand axis"],"prefix":"10.1016","volume":"76","author":[{"given":"Michail","family":"Makris","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paschalis","family":"Evangelidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolaos","family":"Devrikis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pavlos","family":"Simonopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleftheria","family":"Ztriva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vasileios","family":"Patriarcheas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vasiliki","family":"Gougoula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Ntaios","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleni","family":"Gavriilaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgia","family":"Kaiafa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.blre.2026.101365_bb0005","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1016\/S0140-6736(24)00367-2","article-title":"Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990\u20132021: a systematic analysis for the global burden of disease study 2021","volume":"403","author":"Naghavi","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.blre.2026.101365_bb0010","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1177\/17474930241308142","article-title":"World stroke organization: global stroke fact sheet 2025","volume":"20","author":"Feigin","year":"2025","journal-title":"Int J Stroke"},{"key":"10.1016\/j.blre.2026.101365_bb0015","doi-asserted-by":"crossref","first-page":"917","DOI":"10.3390\/jcm13030917","article-title":"Quality indicators and clinical outcomes of acute stroke: results from a prospective multicenter registry in Greece (SUN4P)","volume":"13","author":"Korompoki","year":"2024","journal-title":"J Clin Med"},{"key":"10.1016\/j.blre.2026.101365_bb0020","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1177\/1941875211408731","article-title":"Safety of thrombolysis in acute ischemic stroke: a review of complications, risk factors, and newer technologies","volume":"1","author":"Miller","year":"2011","journal-title":"Neurohospitalist"},{"key":"10.1016\/j.blre.2026.101365_bb0025","article-title":"Endovascular therapy in patients with acute ischemic stroke with large infarct: a guideline from the society of vascular and interventional neurology","volume":"5","author":"Mokin","year":"2025","journal-title":"Stroke Vasc Interv Neurol"},{"key":"10.1016\/j.blre.2026.101365_bb0030","doi-asserted-by":"crossref","DOI":"10.1177\/23969873251329841","article-title":"Prioritizing gaps in stroke care: a two-round Delphi process","author":"Mathijssen","year":"2025","journal-title":"Eur Stroke J"},{"key":"10.1016\/j.blre.2026.101365_bb0035","doi-asserted-by":"crossref","DOI":"10.1161\/CIR.0000000000001052","article-title":"Heart disease and stroke statistics\u20142022 update: a report from the American heart association","volume":"145","author":"Tsao","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.blre.2026.101365_bb0040","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1055\/s-0038-1648251","article-title":"Targeting von Willebrand factor in ischaemic stroke: focus on clinical evidence","volume":"118","author":"Buchtele","year":"2018","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.blre.2026.101365_bb0045","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1212\/WNL.0b013e31829bfde3","article-title":"Epidemiology of stroke and its subtypes in Chinese vs white populations","volume":"81","author":"Tsai","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.blre.2026.101365_bb0050","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1161\/01.STR.31.5.1062","article-title":"Ischemic stroke subtypes","volume":"31","author":"Petty","year":"2000","journal-title":"Stroke"},{"key":"10.1016\/j.blre.2026.101365_bb0055","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.thromres.2013.07.027","article-title":"The clinical implications of ADAMTS13 function: the perspectives of haemostaseologists","volume":"132","author":"Rangarajan","year":"2013","journal-title":"Thromb Res"},{"key":"10.1016\/j.blre.2026.101365_bb0060","doi-asserted-by":"crossref","DOI":"10.1098\/rsob.200333","article-title":"ADAMTS proteases in cardiovascular physiology and disease","volume":"10","author":"Santamaria","year":"2020","journal-title":"Open Biol"},{"key":"10.1016\/j.blre.2026.101365_bb0065","doi-asserted-by":"crossref","first-page":"3600","DOI":"10.1182\/blood-2008-09-180695","article-title":"Deficiency of von Willebrand factor protects mice from ischemic stroke","volume":"113","author":"Kleinschnitz","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.blre.2026.101365_bb0070","doi-asserted-by":"crossref","first-page":"2470","DOI":"10.3390\/jcm14072470","article-title":"Prospective study of ADAMTS13 and von Willebrand factor\u2019s role in the prediction of outcomes in acute ischemic stroke","volume":"14","author":"Makris","year":"2025","journal-title":"J Clin Med"},{"key":"10.1016\/j.blre.2026.101365_bb0075","doi-asserted-by":"crossref","first-page":"3711","DOI":"10.1016\/j.jtha.2025.06.002","article-title":"2025 focused update of the 2020 ISTH guidelines for management of thrombotic thrombocytopenic purpura","volume":"23","author":"Zheng","year":"2025","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.blre.2026.101365_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.tru.2021.100062","article-title":"Updates on thrombotic thrombocytopenic purpura: recent developments in pathogenesis, treatment and survivorship","volume":"5","author":"Sukumar","year":"2021","journal-title":"Thromb Update"},{"key":"10.1016\/j.blre.2026.101365_bb0085","doi-asserted-by":"crossref","first-page":"8137","DOI":"10.3390\/ijms25158137","article-title":"ADAMTS13 in the new era of TTP","volume":"25","author":"Papakonstantinou","year":"2024","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.blre.2026.101365_bb0090","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1182\/blood-2017-04-636431","article-title":"Pathophysiology of thrombotic thrombocytopenic purpura","volume":"130","author":"Sadler","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.blre.2026.101365_bb0095","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1056\/NEJMoa1806311","article-title":"Caplacizumab treatment for acquired thrombotic thrombocytopenic purpura","volume":"380","author":"Scully","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.blre.2026.101365_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2025.103168","article-title":"Caplacizumab use in immune-mediated thrombotic thrombocytopenic purpura: an international multicentre retrospective cohort study (the Capla 1000+ project)","volume":"82","author":"Coppo","year":"2025","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.blre.2026.101365_bb0105","article-title":"Caplacizumab for immune thrombotic thrombocytopenic purpura: real-world multicenter data","volume":"10","author":"Gavriilaki","year":"2023","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.blre.2026.101365_bb0110","doi-asserted-by":"crossref","DOI":"10.1097\/01.HS9.0000968132.86513.06","article-title":"S305: phase 2 randomized, placebo-controlled, double-blind, multicenter study of recombinant ADAMTS13 in patients with immune-mediated thrombotic thrombocytopenic purpura","volume":"7","author":"Scully","year":"2023","journal-title":"Hemasphere"},{"key":"10.1016\/j.blre.2026.101365_bb0115","series-title":"A study of TAK-755 (rADAMTS13) with little to no plasma exchange (PEX) treatment in adults with immune-mediated thrombotic thrombocytopenic purpura (iTTP)","author":"NCT05714969","year":"2025"},{"key":"10.1016\/j.blre.2026.101365_bb0120","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1182\/bloodadvances.2020004169","article-title":"Cardiovascular disease is a leading cause of mortality among TTP survivors in clinical remission","volume":"6","author":"Sukumar","year":"2022","journal-title":"Blood Adv"},{"key":"10.1016\/j.blre.2026.101365_bb0125","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1182\/blood.2019001056","article-title":"Reduced ADAMTS13 activity during TTP remission is associated with stroke in TTP survivors","volume":"134","author":"Upreti","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.blre.2026.101365_bb0130","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2019.00772","article-title":"ADAMTS13: an emerging target in stroke therapy","volume":"10","author":"Chen","year":"2019","journal-title":"Front Neurol"},{"key":"10.1016\/j.blre.2026.101365_bb0135","doi-asserted-by":"crossref","first-page":"2446","DOI":"10.1161\/ATVBAHA.116.308225","article-title":"Von Willebrand factor, ADAMTS13, and the risk of mortality","volume":"36","author":"Sonneveld","year":"2016","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.blre.2026.101365_bb0140","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1161\/STROKEAHA.111.628867","article-title":"von Willebrand Factor","volume":"43","author":"De Meyer","year":"2012","journal-title":"Stroke"},{"key":"10.1016\/j.blre.2026.101365_bb0145","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-34794-w","article-title":"Elevated ADAMTS13 activity is associated with poor postoperative outcome in patients undergoing liver resection","volume":"8","author":"Haegele","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.blre.2026.101365_bb0150","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1097\/MBC.0000000000000405","article-title":"The expression of ADAMTS13 in human microvascular endothelial cells","volume":"27","author":"Wang","year":"2016","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.blre.2026.101365_bb0155","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.thromres.2013.05.024","article-title":"Simvastatin increases ADAMTS13 expression in podocytes","volume":"132","author":"Shen","year":"2013","journal-title":"Thromb Res"},{"key":"10.1016\/j.blre.2026.101365_bb0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neulet.2012.03.002","article-title":"ADAMTS-13 is produced by glial cells and upregulated after spinal cord injury","volume":"517","author":"Tauchi","year":"2012","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.blre.2026.101365_bb0165","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/jth.12221","article-title":"Structure\u2013function and regulation of ADAMTS-13 protease","volume":"11","author":"Zheng","year":"2013","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.blre.2026.101365_bb0170","doi-asserted-by":"crossref","first-page":"18578","DOI":"10.1073\/pnas.1411979112","article-title":"Conformational activation of ADAMTS13","volume":"111","author":"South","year":"2014","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.blre.2026.101365_bb0175","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.02884","article-title":"von Willebrand factor and platelet glycoprotein Ib: a thromboinflammatory axis in stroke","volume":"10","author":"Denorme","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.blre.2026.101365_bb0180","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1111\/jth.14743","article-title":"A sticky proposition: the endothelial glycocalyx and von Willebrand factor","volume":"18","author":"Choi","year":"2020","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.blre.2026.101365_bb0185","doi-asserted-by":"crossref","first-page":"R110","DOI":"10.1016\/S0960-9822(99)80063-3","article-title":"Primary haemostasis: sticky fingers cement the relationship","volume":"9","author":"Clemetson","year":"1999","journal-title":"Curr Biol"},{"key":"10.1016\/j.blre.2026.101365_bb0190","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/j.hoc.2021.07.004","article-title":"Von Willebrand disease","volume":"35","author":"Weyand","year":"2021","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1016\/j.blre.2026.101365_bb0195","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1182\/blood-2006-06-028241","article-title":"von Willebrand factor and factor VIII are independently required to form stable occlusive thrombi in injured veins","volume":"109","author":"Chauhan","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.blre.2026.101365_bb0200","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1182\/blood-2016-04-713289","article-title":"Life in the shadow of a dominant partner: the FVIII-VWF association and its clinical implications for hemophilia A","volume":"128","author":"Pipe","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.blre.2026.101365_bb0205","doi-asserted-by":"crossref","first-page":"2722","DOI":"10.1111\/jth.15873","article-title":"Mechanisms of ADAMTS13 regulation","volume":"20","author":"DeYoung","year":"2022","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.blre.2026.101365_bb0210","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1172\/JCI112394","article-title":"Subunit composition of plasma von Willebrand factor. Cleavage is present in normal individuals, increased in IIA and IIB von Willebrand disease, but minimal in variants with aberrant structure of individual oligomers (types IIC, IID, and IIE)","volume":"77","author":"Zimmerman","year":"1986","journal-title":"J Clin Investig"},{"key":"10.1016\/j.blre.2026.101365_bb0215","doi-asserted-by":"crossref","first-page":"3212","DOI":"10.1182\/blood-2011-02-306597","article-title":"Unraveling the scissile bond: how ADAMTS13 recognizes and cleaves von Willebrand factor","volume":"118","author":"Crawley","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.blre.2026.101365_bb0220","doi-asserted-by":"crossref","first-page":"9226","DOI":"10.1073\/pnas.0903679106","article-title":"Structural specializations of A2, a force-sensing domain in the ultralarge vascular protein von Willebrand factor","volume":"106","author":"Zhang","year":"2009","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.blre.2026.101365_bb0225","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1038\/nature09295","article-title":"A mechanically stabilized receptor\u2013ligand flex-bond important in the vasculature","volume":"466","author":"Kim","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.blre.2026.101365_bb0230","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1111\/j.1538-7836.2008.02989.x","article-title":"Inflammatory cytokines inhibit ADAMTS13 synthesis in hepatic stellate cells and endothelial cells","volume":"6","author":"Cao","year":"2008","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.blre.2026.101365_bb0235","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0247017","article-title":"Characterization of ADAMTS13 and von Willebrand factor levels in septic and non-septic ICU patients","volume":"16","author":"Singh","year":"2021","journal-title":"PloS One"},{"key":"10.1016\/j.blre.2026.101365_bb0240","doi-asserted-by":"crossref","first-page":"e310","DOI":"10.1016\/j.thromres.2010.02.013","article-title":"Association between reduced ADAMTS13 and diabetic nephropathy","volume":"125","author":"Taniguchi","year":"2010","journal-title":"Thromb Res"},{"key":"10.1016\/j.blre.2026.101365_bb0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2020.155265","article-title":"Von Willebrand factor, its cleaving protease (ADAMTS13), and inflammation in young adults: the African-PREDICT study","volume":"136","author":"M\u00f6ller","year":"2020","journal-title":"Cytokine"},{"key":"10.1016\/j.blre.2026.101365_bb0250","doi-asserted-by":"crossref","first-page":"e51","DOI":"10.1182\/blood-2016-06-720912","article-title":"Identification of glycans on plasma-derived ADAMTS13","volume":"128","author":"Verbij","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.blre.2026.101365_bb0255","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1182\/blood-2008-07-167775","article-title":"N-glycans of ADAMTS13 modulate its secretion and von Willebrand factor cleaving activity","volume":"113","author":"Zhou","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.blre.2026.101365_bb0260","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1111\/jth.15170","article-title":"Immunogenic hotspots in the spacer domain of ADAMTS13 in immune-mediated thrombotic thrombocytopenic purpura","volume":"19","author":"Vel\u00e1squez Pereira","year":"2021","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.blre.2026.101365_bb0265","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/jth.14345","article-title":"Pharmacokinetics of plasma infusion in congenital thrombotic thrombocytopenic purpura","volume":"17","author":"Taylor","year":"2019","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.blre.2026.101365_bb0270","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2021.701959","article-title":"Regulation of ADAMTS proteases","volume":"8","author":"Rose","year":"2021","journal-title":"Front Mol Biosci"},{"key":"10.1016\/j.blre.2026.101365_bb0275","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1111\/bjh.16553","article-title":"Platelet factor 4 inhibits ADAMTS13 activity and regulates the multimeric distribution of von Willebrand factor","volume":"190","author":"Nazy","year":"2020","journal-title":"Br J Haematol"},{"key":"10.1016\/j.blre.2026.101365_bb0280","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1182\/blood-2015-12-688747","article-title":"Human neutrophil peptides inhibit cleavage of von Willebrand factor by ADAMTS13: a potential link of inflammation to TTP","volume":"128","author":"Pillai","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.blre.2026.101365_bb0285","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1182\/blood-2004-01-0107","article-title":"Effects of inflammatory cytokines on the release and cleavage of the endothelial cell\u2013derived ultralarge von Willebrand factor multimers under flow","volume":"104","author":"Bernardo","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.blre.2026.101365_bb0290","doi-asserted-by":"crossref","first-page":"e132","DOI":"10.3324\/haematol.2013.092635","article-title":"Thrombospondin-1 inhibits ADAMTS13 activity in sickle cell disease","volume":"98","author":"Novelli","year":"2013","journal-title":"Haematologica"},{"key":"10.1016\/j.blre.2026.101365_bb0295","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1160\/TH08-10-0677","article-title":"Haemoglobin blocks von Willebrand factor proteolysis by ADAMTS-13: a mechanism associated with sickle cell disease","volume":"101","author":"Zhou","year":"2009","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.blre.2026.101365_bb0300","doi-asserted-by":"crossref","DOI":"10.1016\/j.blre.2021.100805","article-title":"Complement in sickle cell disease and targeted therapy: I know one thing, that I know nothing","volume":"48","author":"Tampaki","year":"2021","journal-title":"Blood Rev"},{"key":"10.1016\/j.blre.2026.101365_bb0305","doi-asserted-by":"crossref","DOI":"10.1002\/hem3.135","article-title":"Prospective study of complement activation and thromboinflammation within sickle cell disease and its complications","volume":"8","author":"Varelas","year":"2024","journal-title":"Hemasphere"},{"key":"10.1016\/j.blre.2026.101365_bb0310","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1080\/17474086.2024.2348662","article-title":"What is the role of complement in bystander hemolysis? Old concept, new insights","volume":"17","author":"Evangelidis","year":"2024","journal-title":"Expert Rev Hematol"},{"key":"10.1016\/j.blre.2026.101365_bb0315","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1182\/blood.2018881607","article-title":"Recognition of PF4-VWF complexes by heparin-induced thrombocytopenia antibodies contributes to thrombus propagation","volume":"135","author":"Johnston","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.blre.2026.101365_bb0320","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1111\/j.1538-7836.2010.03942.x","article-title":"Inactivation of ADAMTS13 by plasmin as a potential cause of thrombotic thrombocytopenic purpura","volume":"8","author":"Feys","year":"2010","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.blre.2026.101365_bb0325","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1182\/blood-2005-03-1087","article-title":"Severe secondary deficiency of von Willebrand factor\u2013cleaving protease (ADAMTS13) in patients with sepsis-induced disseminated intravascular coagulation: its correlation with development of renal failure","volume":"107","author":"Ono","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.blre.2026.101365_bb0330","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1182\/blood-2004-03-1101","article-title":"Proteolytic inactivation of ADAMTS13 by thrombin and plasmin","volume":"105","author":"Crawley","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.blre.2026.101365_bb0335","article-title":"Removal of the C-terminal domains of ADAMTS13 by activated coagulation factor XI induces platelet adhesion on endothelial cells under flow conditions","volume":"4","author":"Garland","year":"2017","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.blre.2026.101365_bb0340","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1182\/blood-2018-11-886275","article-title":"Phylogenetic and functional analysis of ADAMTS13 identifies highly conserved domains essential for allosteric regulation","volume":"133","author":"Muia","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.blre.2026.101365_bb0345","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abg4403","article-title":"Crystal structure of ADAMTS13 CUB domains reveals their role in global latency","volume":"7","author":"Kim","year":"2021","journal-title":"Sci Adv"},{"key":"10.1016\/j.blre.2026.101365_bb0350","doi-asserted-by":"crossref","first-page":"30136","DOI":"10.1074\/jbc.M305331200","article-title":"Cleavage of von Willebrand factor requires the spacer domain of the metalloprotease ADAMTS13","volume":"278","author":"Zheng","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.blre.2026.101365_bb0355","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1111\/jth.13445","article-title":"Conformational quiescence of ADAMTS-13 prevents proteolytic promiscuity","volume":"14","author":"South","year":"2016","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.blre.2026.101365_bb0360","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s13036-018-0102-y","article-title":"AFM imaging reveals multiple conformational states of ADAMTS13","volume":"13","author":"Yu","year":"2019","journal-title":"J Biol Eng"},{"key":"10.1016\/j.blre.2026.101365_bb0365","doi-asserted-by":"crossref","first-page":"3746","DOI":"10.1182\/blood-2006-03-010322","article-title":"P-selectin glycoprotein ligand 1 and \u03b22-integrins cooperate in the adhesion of leukocytes to von Willebrand factor","volume":"108","author":"Pendu","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.blre.2026.101365_bb0370","doi-asserted-by":"crossref","first-page":"4712","DOI":"10.1182\/blood-2010-03-276311","article-title":"von Willebrand factor promotes leukocyte extravasation","volume":"116","author":"Petri","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.blre.2026.101365_bb0375","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1182\/bloodadvances.2018023507","article-title":"Humanized GPIb\u03b1\u2013von Willebrand factor interaction in the mouse","volume":"2","author":"Kanaji","year":"2018","journal-title":"Blood Adv"},{"key":"10.1016\/j.blre.2026.101365_bb0380","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1172\/JCI41062","article-title":"N-acetylcysteine reduces the size and activity of von Willebrand factor in human plasma and mice","volume":"121","author":"Chen","year":"2011","journal-title":"J Clin Investig"},{"key":"10.1016\/j.blre.2026.101365_bb0385","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1161\/ATVBAHA.116.308524","article-title":"Plasmin cleaves Von Willebrand factor at K1491-R1492 in the A1\u2013A2 linker region in a shear- and glycan-dependent manner in vitro","volume":"37","author":"Brophy","year":"2017","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.blre.2026.101365_bb0390","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1182\/blood.V98.5.1424","article-title":"Localized reduction of atherosclerosis in von Willebrand factor\u2013deficient mice","volume":"98","author":"Methia","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.blre.2026.101365_bb0395","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/jth.12456","article-title":"ADAMTS13 modulates atherosclerotic plaque progression in mice via a VWF-dependent mechanism","volume":"12","author":"Gandhi","year":"2014","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.blre.2026.101365_bb0400","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1161\/ATVBAHA.117.309918","article-title":"Endothelial cell\u2013derived von Willebrand factor, but not platelet-derived, promotes atherosclerosis in apolipoprotein E\u2013deficient mice","volume":"38","author":"Doddapattar","year":"2018","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.blre.2026.101365_bb0405","doi-asserted-by":"crossref","first-page":"5224","DOI":"10.1182\/blood-2012-06-440255","article-title":"ADAMTS13 deficiency exacerbates VWF-dependent acute myocardial ischemia\/reperfusion injury in mice","volume":"120","author":"Gandhi","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.blre.2026.101365_bb0410","doi-asserted-by":"crossref","first-page":"7184","DOI":"10.1038\/s41598-017-07340-3","article-title":"ADAMTS-13 regulates neutrophil recruitment in a mouse model of invasive pulmonary aspergillosis","volume":"7","author":"Alflen","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.blre.2026.101365_bb0415","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1055\/s-0037-1603927","article-title":"ADAMTS13 deficiency worsens colitis and exogenous ADAMTS13 administration decreases colitis severity in mice","volume":"01","author":"Zitomersky","year":"2017","journal-title":"TH Open"},{"key":"10.1016\/j.blre.2026.101365_bb0420","doi-asserted-by":"crossref","first-page":"F134","DOI":"10.1152\/ajprenal.00405.2018","article-title":"ADAMTS13 protects mice against renal ischemia-reperfusion injury by reducing inflammation and improving endothelial function","volume":"316","author":"Zhou","year":"2019","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.blre.2026.101365_bb0425","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.mvr.2012.05.004","article-title":"ADAMTS13 promotes angiogenesis and modulates VEGF-induced angiogenesis","volume":"84","author":"Lee","year":"2012","journal-title":"Microvasc Res"},{"key":"10.1016\/j.blre.2026.101365_bb0430","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s00018-014-1667-3","article-title":"ADAMTS13 and its variants promote angiogenesis via upregulation of VEGF and VEGFR2","volume":"72","author":"Lee","year":"2015","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.blre.2026.101365_bb0435","doi-asserted-by":"crossref","first-page":"L35","DOI":"10.1016\/j.bpj.2010.01.032","article-title":"Elongational flow induces the unfolding of von Willebrand factor at physiological flow rates","volume":"98","author":"Sing","year":"2010","journal-title":"Biophys J"},{"key":"10.1016\/j.blre.2026.101365_bb0440","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1182\/blood-2008-02-142943","article-title":"Altered thrombus formation in von Willebrand factor\u2013deficient mice expressing von Willebrand factor variants with defective binding to collagen or GPIIbIIIa","volume":"112","author":"Marx","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.blre.2026.101365_bb0445","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1160\/TH14-04-0336","article-title":"Mechanism and functional impact of CD40 ligand-induced von Willebrand factor release from endothelial cells","volume":"113","author":"M\u00f6ller","year":"2015","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.blre.2026.101365_bb0450","doi-asserted-by":"crossref","first-page":"2524","DOI":"10.1161\/01.ATV.19.10.2524","article-title":"Intimal deposition of functional von Willebrand factor in atherogenesis","volume":"19","author":"De Meyer","year":"1999","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.blre.2026.101365_bb0455","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1111\/j.1538-7836.2012.04822.x","article-title":"ADAMTS13 reduces VWF-mediated acute inflammation following focal cerebral ischemia in mice","volume":"10","author":"Khan","year":"2012","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.blre.2026.101365_bb0460","doi-asserted-by":"crossref","first-page":"6672","DOI":"10.3390\/jcm14186672","article-title":"Activated complement system\u2019s impact in antiphospholipid syndrome thrombosis: from pathophysiology to treatment","volume":"14","author":"Tagara","year":"2025","journal-title":"J Clin Med"},{"key":"10.1016\/j.blre.2026.101365_bb0465","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1038\/nri.2017.105","article-title":"Neutrophil extracellular traps in immunity and disease","volume":"18","author":"Papayannopoulos","year":"2018","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.blre.2026.101365_bb0470","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1111\/j.1538-7836.2012.04820.x","article-title":"Stroke-associated inflammation: is von Willebrand factor a \u2018bad guy\u2019?","volume":"10","author":"Brill","year":"2012","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.blre.2026.101365_bb0475","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1161\/ATVBAHA.112.250993","article-title":"Extracellular chromatin is an important mediator of ischemic stroke in mice","volume":"32","author":"De Meyer","year":"2012","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.blre.2026.101365_bb0480","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.resuscitation.2005.05.021","article-title":"Plasma DNA as a prognostic marker for stroke patients with negative neuroimaging within the first 24h of symptom onset","volume":"68","author":"Lam","year":"2006","journal-title":"Resuscitation"},{"key":"10.1016\/j.blre.2026.101365_bb0485","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.tips.2024.05.008","article-title":"Targeting extranuclear histones to alleviate acute and chronic inflammation","volume":"45","author":"Nicolaes","year":"2024","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.blre.2026.101365_bb0490","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1172\/JCI200421655","article-title":"Neutrophil protein kinase C\u03b4 as a mediator of stroke-reperfusion injury","volume":"114","author":"Chou","year":"2004","journal-title":"J Clin Investig"},{"key":"10.1016\/j.blre.2026.101365_bb0495","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1161\/STROKEAHA.108.534503","article-title":"Temporal and spatial dynamics of cerebral immune cell accumulation in stroke","volume":"40","author":"Gelderblom","year":"2009","journal-title":"Stroke"},{"key":"10.1016\/j.blre.2026.101365_bb0500","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.813995","article-title":"Weibel Palade bodies: unique secretory organelles of endothelial cells that control blood vessel homeostasis","volume":"9","author":"Na\u00df","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.blre.2026.101365_bb0505","doi-asserted-by":"crossref","first-page":"3329","DOI":"10.1182\/blood-2009-03-213264","article-title":"von Willebrand factor\u2013cleaving protease ADAMTS13 reduces ischemic brain injury in experimental stroke","volume":"114","author":"Zhao","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.blre.2026.101365_bb0510","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1161\/ATVBAHA.110.208918","article-title":"Binding of von Willebrand factor to collagen and glycoprotein Ib\u03b1, but not to glycoprotein IIb\/IIIa, contributes to ischemic stroke in mice\u2014brief report","volume":"30","author":"De Meyer","year":"2010","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.blre.2026.101365_bb0515","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1161\/CIRCULATIONAHA.107.691279","article-title":"Targeting platelets in acute experimental stroke","volume":"115","author":"Kleinschnitz","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.blre.2026.101365_bb0520","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/2040-7378-3-9","article-title":"Platelet glycoprotein Ib\u03b1 is an important mediator of ischemic stroke in mice","volume":"3","author":"De Meyer","year":"2011","journal-title":"Exp Transl Stroke Med"},{"key":"10.1016\/j.blre.2026.101365_bb0525","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1182\/blood-2009-06-230110","article-title":"ADAMTS13 gene deletion aggravates ischemic brain damage: a possible neuroprotective role of ADAMTS13 by ameliorating postischemic hypoperfusion","volume":"115","author":"Fujioka","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.blre.2026.101365_bb0530","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1007\/s10072-011-0913-9","article-title":"ADAMTS13 gene deletion enhances plasma high-mobility group box1 elevation and neuroinflammation in brain ischemia\u2013reperfusion injury","volume":"33","author":"Fujioka","year":"2012","journal-title":"Neurol Sci"},{"key":"10.1016\/j.blre.2026.101365_bb0535","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1182\/blood-2015-03-632901","article-title":"Platelet-derived VWF is not essential for normal thrombosis and hemostasis but fosters ischemic stroke injury in mice","volume":"126","author":"Verhenne","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.blre.2026.101365_bb0540","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1161\/ATVBAHA.116.307660","article-title":"Endothelial cell\u2013derived von Willebrand factor is the major determinant that mediates von Willebrand factor\u2013dependent acute ischemic stroke by promoting postischemic thrombo-inflammation","volume":"36","author":"Dhanesha","year":"2016","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.blre.2026.101365_bb0545","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1161\/CIRCRESAHA.118.313818","article-title":"CD69 plays a beneficial role in ischemic stroke by dampening endothelial activation","volume":"124","author":"Brait","year":"2019","journal-title":"Circ Res"},{"key":"10.1016\/j.blre.2026.101365_bb0550","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s12974-017-0792-y","article-title":"Blocking of platelet glycoprotein receptor Ib reduces \u201cthrombo-inflammation\u201d in mice with acute ischemic stroke","volume":"14","author":"Schuhmann","year":"2017","journal-title":"J Neuroinflammation"},{"key":"10.1016\/j.blre.2026.101365_bb0555","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.bbi.2017.11.019","article-title":"Platelet glycoprotein receptor Ib blockade ameliorates experimental cerebral ischemia\u2013reperfusion injury by strengthening the blood\u2013brain barrier function and anti-thrombo-inflammatory property","volume":"69","author":"Chen","year":"2018","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.blre.2026.101365_bb0560","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ejphar.2017.04.002","article-title":"Anfibatide protects against rat cerebral ischemia\/reperfusion injury via TLR4\/JNK\/caspase-3 pathway","volume":"807","author":"Luo","year":"2017","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.blre.2026.101365_bb0565","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2022.175032","article-title":"Anfibatide alleviates inflammation and apoptosis via inhibiting NF-kappaB\/NLRP3 axis in ischemic stroke","volume":"926","author":"Li","year":"2022","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.blre.2026.101365_bb0570","doi-asserted-by":"crossref","first-page":"3904","DOI":"10.1111\/bph.13178","article-title":"A novel snake venom-derived GPIb antagonist, anfibatide, protects mice from acute experimental ischaemic stroke and reperfusion injury","volume":"172","author":"Li","year":"2015","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.blre.2026.101365_bb0575","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111698","article-title":"Blockade of platelet glycoprotein receptor Ib ameliorates blood-brain barrier disruption following ischemic stroke via Epac pathway","volume":"140","author":"Chu","year":"2021","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.blre.2026.101365_bb0580","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s12031-019-01402-z","article-title":"Anfibatide preserves blood\u2013brain barrier integrity by inhibiting TLR4\/RhoA\/ROCK pathway after cerebral ischemia\/reperfusion injury in rat","volume":"70","author":"Gong","year":"2020","journal-title":"J Mol Neurosci"},{"key":"10.1016\/j.blre.2026.101365_bb0585","doi-asserted-by":"crossref","first-page":"819","DOI":"10.3324\/haematol.2019.241042","article-title":"The von Willebrand factor A1 domain mediates thromboinflammation, aggravating ischemic stroke outcome in mice","volume":"106","author":"Denorme","year":"2020","journal-title":"Haematologica"},{"key":"10.1016\/j.blre.2026.101365_bb0590","doi-asserted-by":"crossref","DOI":"10.1016\/j.rpth.2022.100028","article-title":"Spatiotemporal profile of neutrophil extracellular trap formation in a mouse model of ischemic stroke","volume":"7","author":"De Wilde","year":"2023","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.blre.2026.101365_bb0595","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1182\/bloodadvances.2024014622","article-title":"Imbalanced VWF-ADAMTS13 axis contributes to the detrimental impact of a preceding respiratory tract infection on stroke","volume":"9","author":"Patel","year":"2025","journal-title":"Blood Adv"},{"key":"10.1016\/j.blre.2026.101365_bb0600","doi-asserted-by":"crossref","first-page":"3502","DOI":"10.1161\/STROKEAHA.115.011114","article-title":"Efficacy and safety of platelet glycoprotein receptor blockade in aged and comorbid mice with acute experimental stroke","volume":"46","author":"Kraft","year":"2015","journal-title":"Stroke"},{"key":"10.1016\/j.blre.2026.101365_bb0605","doi-asserted-by":"crossref","first-page":"3354","DOI":"10.1182\/blood-2013-12-543074","article-title":"GpIb\u03b1-VWF blockade restores vessel patency by dissolving platelet aggregates formed under very high shear rate in mice","volume":"123","author":"Le Behot","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.blre.2026.101365_bb0610","first-page":"18115","article-title":"miR-525-5p inhibits ADAMTS13 and is correlated with ischemia\/reperfusion injury-induced neuronal cell death","volume":"8","author":"Zhao","year":"2015","journal-title":"Int J Clin Exp Med"},{"key":"10.1016\/j.blre.2026.101365_bb0615","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1097\/WNR.0000000000002017","article-title":"ADAMTS13 deficiency exacerbates neuroinflammation by targeting matrix metalloproteinase-9 in ischemic brain injury","volume":"35","author":"Jiang","year":"2024","journal-title":"Neuroreport"},{"key":"10.1016\/j.blre.2026.101365_bb0620","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1161\/01.CIR.100.7.736","article-title":"Prospective study of markers of hemostatic function with risk of ischemic stroke","volume":"100","author":"Folsom","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.blre.2026.101365_bb0625","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1161\/STROKEAHA.111.636373","article-title":"Fibrin D-dimer, tissue-type plasminogen activator, von Willebrand factor, and risk of incident stroke in older men","volume":"43","author":"Wannamethee","year":"2012","journal-title":"Stroke"},{"key":"10.1016\/j.blre.2026.101365_bb0630","doi-asserted-by":"crossref","first-page":"3080","DOI":"10.1161\/CIRCULATIONAHA.105.557132","article-title":"Which hemostatic markers add to the predictive value of conventional risk factors for coronary heart disease and ischemic stroke?","volume":"112","author":"Smith","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.blre.2026.101365_bb0635","doi-asserted-by":"crossref","first-page":"3321","DOI":"10.1161\/01.ATV.17.11.3321","article-title":"Hemostatic factors as predictors of ischemic heart disease and stroke in the Edinburgh artery study","volume":"17","author":"Smith","year":"1997","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.blre.2026.101365_bb0640","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1161\/CIRCULATIONAHA.106.635029","article-title":"Relative value of inflammatory, hemostatic, and rheological factors for incident myocardial infarction and stroke","volume":"115","author":"Tzoulaki","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.blre.2026.101365_bb0645","doi-asserted-by":"crossref","first-page":"2739","DOI":"10.1182\/blood-2015-05-643338","article-title":"Low ADAMTS13 activity is associated with an increased risk of ischemic stroke","volume":"126","author":"Sonneveld","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.blre.2026.101365_bb0650","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1161\/STROKEAHA.110.586289","article-title":"High von Willebrand factor levels increase the risk of stroke","volume":"41","author":"Wieberdink","year":"2010","journal-title":"Stroke"},{"key":"10.1016\/j.blre.2026.101365_bb0655","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1111\/j.1538-7836.2012.04634.x","article-title":"Genetic determinants of von Willebrand factor plasma levels and the risk of stroke: the Rotterdam study","volume":"10","author":"van Schie","year":"2012","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.blre.2026.101365_bb0660","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1111\/jth.13479","article-title":"Low ADAMTS-13 activity and the risk of coronary heart disease \u2013 a prospective cohort study: the Rotterdam study","volume":"14","author":"Sonneveld","year":"2016","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.blre.2026.101365_bb0665","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s12959-017-0151-3","article-title":"vWF\/ADAMTS13 is associated with on-aspirin residual platelet reactivity and clinical outcome in patients with stable coronary artery disease","volume":"15","author":"Warlo","year":"2017","journal-title":"Thromb J"},{"key":"10.1016\/j.blre.2026.101365_bb0670","doi-asserted-by":"crossref","first-page":"3141","DOI":"10.1161\/01.CIR.0000077912.12202.FC","article-title":"Prognostic value of plasma von Willebrand factor and soluble P-selectin as indices of endothelial damage and platelet activation in 994 patients with nonvalvular atrial fibrillation","volume":"107","author":"Conway","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.blre.2026.101365_bb0675","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1161\/01.STR.0000244767.39962.f7","article-title":"High von Willebrand factor levels increase the risk of first ischemic stroke","volume":"37","author":"Bongers","year":"2006","journal-title":"Stroke"},{"key":"10.1016\/j.blre.2026.101365_bb0680","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1182\/blood-2011-09-380618","article-title":"High VWF, low ADAMTS13, and oral contraceptives increase the risk of ischemic stroke and myocardial infarction in young women","volume":"119","author":"Andersson","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.blre.2026.101365_bb0685","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.atherosclerosis.2009.04.013","article-title":"Lower levels of ADAMTS13 are associated with cardiovascular disease in young patients","volume":"207","author":"Bongers","year":"2009","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.blre.2026.101365_bb0690","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0179258","article-title":"Reduced ADAMTS13 levels in patients with acute and chronic cerebrovascular disease","volume":"12","author":"Denorme","year":"2017","journal-title":"PloS One"},{"key":"10.1016\/j.blre.2026.101365_bb0695","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1177\/1076029615583347","article-title":"Assessment of the diagnostic value of plasma levels, activities, and their ratios of von Willebrand factor and ADAMTS13 in patients with cerebral infarction","volume":"22","author":"Qu","year":"2016","journal-title":"Clin Appl Thromb Hemost"},{"key":"10.1016\/j.blre.2026.101365_bb0700","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.1111\/j.1538-7836.2006.02161.x","article-title":"Reduced von Willebrand factor-cleaving protease (ADAMTS13) activity in acute myocardial infarction","volume":"4","author":"Kaikita","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.blre.2026.101365_bb0705","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1212\/WNL.49.6.1552","article-title":"Von Willebrand factor and risk of ischemic stroke","volume":"49","author":"Qizilbash","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/j.blre.2026.101365_bb0710","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1111\/j.1538-7836.2010.03863.x","article-title":"von Willebrand factor propeptide and the occurrence of a first ischemic stroke","volume":"8","author":"van Schie","year":"2010","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.blre.2026.101365_bb0715","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0099851","article-title":"Von Willebrand factor regulation in patients with acute and chronic cerebrovascular disease: a pilot, case\u2013control study","volume":"9","author":"Kraft","year":"2014","journal-title":"PloS One"},{"key":"10.1016\/j.blre.2026.101365_bb0720","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jns.2014.10.035","article-title":"Relationship between ADAMTS13 activity, von Willebrand factor antigen levels and platelet function in the early and late phases after TIA or ischaemic stroke","volume":"348","author":"McCabe","year":"2015","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.blre.2026.101365_bb0725","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.jns.2017.02.045","article-title":"Profile of von Willebrand factor antigen and von Willebrand factor propeptide in an overall TIA and ischaemic stroke population and amongst subtypes","volume":"375","author":"Tobin","year":"2017","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.blre.2026.101365_bb0730","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1111\/j.1538-7836.2009.03617.x","article-title":"Association between genetic variation at the ADAMTS13 locus and ischemic stroke","volume":"7","author":"Hanson","year":"2009","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.blre.2026.101365_bb0735","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S0049-3848(01)00389-9","article-title":"The Sma I polymorphism in the von Willebrand factor gene associated with acute ischemic stroke","volume":"104","author":"Dai","year":"2001","journal-title":"Thromb Res"},{"key":"10.1016\/j.blre.2026.101365_bb0740","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/j.1538-7836.2010.04134.x","article-title":"Plasma levels of von Willebrand factor in the etiologic subtypes of ischemic stroke","volume":"9","author":"Hanson","year":"2011","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.blre.2026.101365_bb0745","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1055\/s-0038-1656120","article-title":"von Willebrand factor and factor VIII: C in acute cerebrovascular disease. Relationship to stroke subtype and mortality","volume":"77","author":"Catto","year":"1997","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.blre.2026.101365_bb0750","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.atherosclerosis.2013.07.046","article-title":"Relationship of Von Willebrand factor with carotid artery and aortic arch calcification in ischemic stroke patients","volume":"230","author":"Sonneveld","year":"2013","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.blre.2026.101365_bb0755","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/s00508-017-1200-4","article-title":"Clinical role of von Willebrand factor in acute ischemic stroke","volume":"129","author":"Menih","year":"2017","journal-title":"Wien Klin Wochenschr"},{"key":"10.1016\/j.blre.2026.101365_bb0760","doi-asserted-by":"crossref","first-page":"3929","DOI":"10.12659\/MSM.908441","article-title":"The role of von Willebrand factor, ADAMTS13, and cerebral artery thrombus composition in patient outcome following mechanical thrombectomy for acute ischemic stroke","volume":"24","author":"Prochazka","year":"2018","journal-title":"Med Sci Monit"},{"key":"10.1016\/j.blre.2026.101365_bb0765","doi-asserted-by":"crossref","first-page":"2789","DOI":"10.1161\/STROKEAHA.114.006394","article-title":"Von Willebrand factor drives the association between elevated factor VIII and poor outcomes in patients with ischemic stroke","volume":"45","author":"Samai","year":"2014","journal-title":"Stroke"},{"key":"10.1016\/j.blre.2026.101365_bb0770","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1161\/STROKEAHA.106.474569","article-title":"Predictive variables for mortality after acute ischemic stroke","volume":"38","author":"Carter","year":"2007","journal-title":"Stroke"},{"key":"10.1016\/j.blre.2026.101365_bb0775","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2017.00721","article-title":"Elevated factor VIII and von Willebrand factor levels predict unfavorable outcome in stroke patients treated with intravenous thrombolysis","volume":"8","author":"T\u00f3th","year":"2018","journal-title":"Front Neurol"},{"key":"10.1016\/j.blre.2026.101365_bb0780","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1182\/bloodadvances.2019000979","article-title":"von Willebrand factor\/ADAMTS13 ratio at presentation of acute ischemic brain injury is predictive of outcome","volume":"4","author":"Taylor","year":"2020","journal-title":"Blood Adv"},{"key":"10.1016\/j.blre.2026.101365_bb0785","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000005162","article-title":"Usefulness of ADAMTS13 to predict response to recanalization therapies in acute ischemic stroke","volume":"90","author":"Bustamante","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/j.blre.2026.101365_bb0790","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1212\/WNL.0000000000005169","article-title":"Personalizing acute therapies for ischemic stroke","volume":"90","author":"Lee","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/j.blre.2026.101365_bb0795","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1055\/s-0038-1637732","article-title":"ADAMTS-13 activity predicts outcome in acute ischaemic stroke patients undergoing endovascular treatment","volume":"47","author":"Schuppner","year":"2018","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.blre.2026.101365_bb0800","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.1161\/STROKEAHA.112.657007","article-title":"IL1B and VWF variants are associated with fibrinolytic early recanalization in patients with ischemic stroke","volume":"43","author":"Fern\u00e1ndez-Cadenas","year":"2012","journal-title":"Stroke"},{"key":"10.1016\/j.blre.2026.101365_bb0805","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1161\/STROKEAHA.116.015677","article-title":"Genetic drivers of von Willebrand factor levels in an ischemic stroke population and association with risk for recurrent stroke","volume":"48","author":"Williams","year":"2017","journal-title":"Stroke"},{"key":"10.1016\/j.blre.2026.101365_bb0810","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1002\/ana.23735","article-title":"Role of reduced ADAMTS13 in arterial ischemic stroke: a pediatric cohort study","volume":"73","author":"Lambers","year":"2013","journal-title":"Ann Neurol"},{"key":"10.1016\/j.blre.2026.101365_bb0815","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1161\/CIRCGENETICS.115.001184","article-title":"Rare variants in the ADAMTS13 von Willebrand factor\u2013binding domain contribute to pediatric stroke","volume":"9","author":"Stoll","year":"2016","journal-title":"Circ Cardiovasc Genet"},{"key":"10.1016\/j.blre.2026.101365_bb0820","doi-asserted-by":"crossref","first-page":"5231","DOI":"10.1182\/blood-2012-07-442038","article-title":"A genome-wide association study identifies a gene network of ADAMTS genes in the predisposition to pediatric stroke","volume":"120","author":"Arning","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.blre.2026.101365_bb0825","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1160\/TH16-01-0036","article-title":"The VWF-GPIb axis in ischaemic stroke: lessons from animal models","volume":"116","author":"Denorme","year":"2016","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.blre.2026.101365_bb0830","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1186\/s12951-024-02900-y","article-title":"Discovery of nanobodies: a comprehensive review of their applications and potential over the past five years","volume":"22","author":"Alexander","year":"2024","journal-title":"J Nanobiotechnol"},{"key":"10.1016\/j.blre.2026.101365_bb0835","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1002\/ajh.27487","article-title":"Current state and potential applications of neonatal Fc receptor (FcRn) inhibitors in hematologic conditions","volume":"99","author":"Jacobs","year":"2024","journal-title":"Am J Hematol"},{"key":"10.1016\/j.blre.2026.101365_bb0840","doi-asserted-by":"crossref","first-page":"6833","DOI":"10.3390\/ijms25136833","article-title":"New insights into aptamers: an alternative to antibodies in the detection of molecular biomarkers","volume":"25","author":"Domsicova","year":"2024","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.blre.2026.101365_bb0845","doi-asserted-by":"crossref","DOI":"10.4172\/2155-9562.1000146","article-title":"Synergistic effect of AJW200, a von Willebrand factor neutralizing antibody with low dose (0.9 mg\/mg) thrombolytic therapy following embolic stroke in rabbits","volume":"04","author":"Lapchak","year":"2013","journal-title":"J Neurol Neurophysiol"},{"key":"10.1016\/j.blre.2026.101365_bb0850","doi-asserted-by":"crossref","first-page":"5088","DOI":"10.1182\/blood-2012-11-464545","article-title":"Reperfusion of cerebral artery thrombosis by the GPIb\u2013VWF blockade with the nanobody ALX-0081 reduces brain infarct size in guinea pigs","volume":"121","author":"Momi","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.blre.2026.101365_bb0855","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1161\/CIRCULATIONAHA.117.027290","article-title":"Potent thrombolytic effect of N-acetylcysteine on arterial thrombi","volume":"136","author":"Martinez de Lizarrondo","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.blre.2026.101365_bb0860","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1161\/STROKEAHA.123.045880","article-title":"R-tPA resistance is specific for platelet-rich stroke thrombi and can be overcome by targeting nonfibrin components","volume":"55","author":"Vandelanotte","year":"2024","journal-title":"Stroke"},{"key":"10.1016\/j.blre.2026.101365_bb0865","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1038\/s41598-023-49054-9","article-title":"Safety and efficacy of N-acetylcysteine (NAC) as an adjunct to standard treatment in patients with acute ischemic stroke: a randomized controlled pilot trial (NACTLYS)","volume":"14","author":"Komakula","year":"2024","journal-title":"Sci Rep"},{"key":"10.1016\/j.blre.2026.101365_bb0870","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.neuroscience.2025.08.006","article-title":"N-acetylcysteine (NAC) as an adjunct to intravenous fibrinolysis in patients with acute ischemic stroke: a single group study (NAC-safety)","volume":"584","author":"Vivien","year":"2025","journal-title":"Neuroscience"},{"key":"10.1016\/j.blre.2026.101365_bb0875","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1016\/j.ymthe.2019.03.016","article-title":"Preclinical development of a vWF aptamer to limit thrombosis and engender arterial recanalization of occluded vessels","volume":"27","author":"Nimjee","year":"2019","journal-title":"Mol Ther"},{"key":"10.1016\/j.blre.2026.101365_bb0880","doi-asserted-by":"crossref","DOI":"10.1161\/str.54.suppl_1.94","article-title":"Abstract 94: randomized, double-blind, placebo-controlled phase 1 study of Vwf-binding aptamer, bb-031: safety, tolerability, pharmacokinetic and Pharmacodynamic activity in healthy volunteers","volume":"54","author":"Nimjee","year":"2023","journal-title":"Stroke"},{"key":"10.1016\/j.blre.2026.101365_bb0885","series-title":"Study of BB-031 in acute ischemic stroke patients (RAISE)","author":"NCT06226805","year":"2025"},{"key":"10.1016\/j.blre.2026.101365_bb0890","doi-asserted-by":"crossref","first-page":"2844","DOI":"10.1182\/blood.2022016342","article-title":"VWF-targeted thrombolysis to overcome rh-tPA resistance in experimental murine ischemic stroke models","volume":"140","author":"van Moorsel","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.blre.2026.101365_bb0895","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1182\/blood-2025-849","article-title":"Novel von willebrand factor targeting thrombolytic TGD001 is safe and well tolerated in a phase 1 first-in-human trial","volume":"146","author":"Scully","year":"2025","journal-title":"Blood"},{"key":"10.1016\/j.blre.2026.101365_bb0900","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1111\/jth.14755","article-title":"The development and characterization of a long acting anti-thrombotic von Willebrand factor (VWF) aptamer","volume":"18","author":"Zhu","year":"2020","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.blre.2026.101365_bb0905","doi-asserted-by":"crossref","first-page":"3092","DOI":"10.1038\/s41598-021-82747-7","article-title":"The aptamer BT200 blocks von Willebrand factor and platelet function in blood of stroke patients","volume":"11","author":"Kovacevic","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.blre.2026.101365_bb0910","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-68125-9","article-title":"The aptamer BT200 effectively inhibits von Willebrand factor (VWF) dependent platelet function after stimulated VWF release by desmopressin or endotoxin","volume":"10","author":"Kovacevic","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.blre.2026.101365_bb0915","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.3324\/haematol.2021.279948","article-title":"The von Willebrand factor A-1 domain binding aptamer BT200 elevates plasma levels of von Willebrand factor and factor VIII: a first-in-human trial","volume":"107","author":"Kovacevic","year":"2021","journal-title":"Haematologica"},{"key":"10.1016\/j.blre.2026.101365_bb0920","doi-asserted-by":"crossref","first-page":"4351","DOI":"10.3390\/ijms25084351","article-title":"Molecular pathways of vulnerable carotid plaques at risk of ischemic stroke: a narrative review","volume":"25","author":"Miceli","year":"2024","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.blre.2026.101365_bb0925","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1161\/STROKEAHA.120.032810","article-title":"Thrombus composition and efficacy of thrombolysis and thrombectomy in acute ischemic stroke","volume":"52","author":"Jolugbo","year":"2021","journal-title":"Stroke"},{"key":"10.1016\/j.blre.2026.101365_bb0930","doi-asserted-by":"crossref","first-page":"498","DOI":"10.3324\/haematol.2019.219881","article-title":"Structural analysis of ischemic stroke thrombi: histological indications for therapy resistance","volume":"105","author":"Staessens","year":"2020","journal-title":"Haematologica"},{"key":"10.1016\/j.blre.2026.101365_bb0935","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1161\/STROKEAHA.124.047092","article-title":"Association between thrombus composition and etiology in patients with acute ischemic stroke treated by thrombectomy","volume":"56","author":"Staessens","year":"2025","journal-title":"Stroke"},{"key":"10.1016\/j.blre.2026.101365_bb0940","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1136\/jnis-2023-020594","article-title":"MR microscopy to assess clot composition following mechanical thrombectomy predicts recanalization and clinical outcome","volume":"16","author":"Karimian-Jazi","year":"2024","journal-title":"J Neurointerv Surg"},{"key":"10.1016\/j.blre.2026.101365_bb0945","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1007\/s00062-017-0599-3","article-title":"Differentiation of clot composition using conventional and dual-energy computed tomography","volume":"28","author":"Borggrefe","year":"2018","journal-title":"Clin Neuroradiol"},{"key":"10.1016\/j.blre.2026.101365_bb0950","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1136\/neurintsurg-2020-016774","article-title":"Imaging-based prediction of histological clot composition from admission CT imaging","volume":"13","author":"Hanning","year":"2021","journal-title":"J Neurointerv Surg"},{"key":"10.1016\/j.blre.2026.101365_bb0955","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1159\/000337940","article-title":"Relations between plasma von Willebrand factor or endothelin-1 and restenosis following carotid artery stenting","volume":"21","author":"Yang","year":"2012","journal-title":"Med Princ Pract"},{"key":"10.1016\/j.blre.2026.101365_bb0960","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1161\/STROKEAHA.111.616649","article-title":"The von Willebrand inhibitor ARC1779 reduces cerebral embolization after carotid endarterectomy","volume":"42","author":"Markus","year":"2011","journal-title":"Stroke"},{"key":"10.1016\/j.blre.2026.101365_bb0965","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ejvs.2007.03.011","article-title":"Influence of antiplatelet therapy on cerebral micro-emboli after carotid endarterectomy using postoperative transcranial doppler monitoring","volume":"34","author":"de Borst","year":"2007","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.blre.2026.101365_bb0970","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.thromres.2024.03.019","article-title":"Cancer patients and ischemic stroke","volume":"237","author":"Kawano","year":"2024","journal-title":"Thromb Res"},{"key":"10.1016\/j.blre.2026.101365_bb0975","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.123.032284","article-title":"Von Willebrand factor antigen levels predict poor outcomes in patients with stroke and cancer: findings from the multicenter, prospective, observational SCAN study","volume":"13","author":"Kawano","year":"2024","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.blre.2026.101365_bb0980","doi-asserted-by":"crossref","DOI":"10.3390\/jcdd12050183","article-title":"Prevalence and risk factors of acute ischemic stroke in patients with antiphospholipid syndrome: a retrospective monocenter analysis","volume":"12","author":"Evangelidis","year":"2025","journal-title":"J Cardiovasc Dev Dis"},{"key":"10.1016\/j.blre.2026.101365_bb0985","doi-asserted-by":"crossref","DOI":"10.1111\/cns.70321","article-title":"The association of serum biomarkers with symptomatic hemorrhagic transformation in acute ischemic stroke patients: a combined retrospective and prospective study","volume":"31","author":"Yuan","year":"2025","journal-title":"CNS Neurosci Ther"},{"key":"10.1016\/j.blre.2026.101365_bb0990","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2024.1436291","article-title":"Von Willebrand factor targeted thrombolysis in canine basilar artery occlusion","volume":"15","author":"Carfora","year":"2024","journal-title":"Front Neurol"},{"key":"10.1016\/j.blre.2026.101365_bb0995","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.brainres.2015.07.027","article-title":"Delayed treatment with ADAMTS13 ameliorates cerebral ischemic injury without hemorrhagic complication","volume":"1624","author":"Nakano","year":"2015","journal-title":"Brain Res"},{"key":"10.1016\/j.blre.2026.101365_bb1000","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1182\/blood-2015-08-662650","article-title":"ADAMTS13-mediated thrombolysis of t-PA-resistant occlusions in ischemic stroke in mice","volume":"127","author":"Denorme","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.blre.2026.101365_bb1005","article-title":"Tissue plasminogen activator neurotoxicity is neutralized by recombinant ADAMTS 13","volume":"6","author":"Fan","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.blre.2026.101365_bb1010","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1111\/jth.14275","article-title":"Enhanced activity of an ADAMTS-13 variant (R568K\/F592Y\/R660K\/Y661F\/Y665F) against platelet agglutination in vitro and in a murine model of acute ischemic stroke","volume":"16","author":"South","year":"2018","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.blre.2026.101365_bb1015","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1182\/blood.2021012787","article-title":"Robust thrombolytic and anti-inflammatory action of a constitutively active ADAMTS13 variant in murine stroke models","volume":"139","author":"South","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.blre.2026.101365_bb1020","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.117166","article-title":"Inhibition of neutrophil rolling and migration by caADAMTS13 in vitro and in mouse models of thrombosis and inflammation","volume":"178","author":"South","year":"2024","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.blre.2026.101365_bb1025","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1161\/STROKEAHA.125.050848","article-title":"Comparison of the novel thrombolytic constitutively active ADAMTS13 with clinical thrombolytics in a murine stroke model","volume":"56","author":"Roberts","year":"2025","journal-title":"Stroke"},{"key":"10.1016\/j.blre.2026.101365_bb1030","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1002\/ana.23762","article-title":"Recombinant ADAMTS13 reduces tissue plasminogen activator-induced hemorrhage after stroke in mice","volume":"73","author":"Wang","year":"2013","journal-title":"Ann Neurol"},{"key":"10.1016\/j.blre.2026.101365_bb1035","doi-asserted-by":"crossref","first-page":"2695","DOI":"10.1182\/bloodadvances.2024015212","article-title":"Development of a protease-resistant ADAMTS13 to improve stability against proteolytic degradation","volume":"9","author":"DeYoung","year":"2025","journal-title":"Blood Adv"},{"key":"10.1016\/j.blre.2026.101365_bb1040","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1111\/jth.15649","article-title":"Constitutively active ADAMTS13: an emerging thrombolytic agent for acute ischemic stroke","volume":"20","author":"Nayak","year":"2022","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.blre.2026.101365_bb1045","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1182\/blood-2025-739","article-title":"VWF:ADAMTS13 ratio is associated with white matter hyperintensity","volume":"146","author":"Story","year":"2025","journal-title":"Blood"},{"key":"10.1016\/j.blre.2026.101365_bb1050","doi-asserted-by":"crossref","DOI":"10.1016\/j.bvth.2024.100025","article-title":"EASIX and m-EASIX predict severe cytokine release syndrome and overall survival after CAR T-cell therapy","volume":"1","author":"Gavriilaki","year":"2024","journal-title":"Blood Vessel Thromb Hemost"}],"container-title":["Blood Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0268960X26000044?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0268960X26000044?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:10:12Z","timestamp":1788221412000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0268960X26000044"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":210,"alternative-id":["S0268960X26000044"],"URL":"https:\/\/doi.org\/10.1016\/j.blre.2026.101365","relation":{},"ISSN":["0268-960X"],"issn-type":[{"value":"0268-960X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reinventing the wheel in ischemic stroke: Novel aspects in ADAMTS13 and von Willebrand axis","name":"articletitle","label":"Article Title"},{"value":"Blood Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.blre.2026.101365","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101365"}}